Article Details
Retrieved on: 2024-02-18 17:59:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
This came after the drug major AstraZeneca presented protocol amendment version 3.0 dated 01/Sep/2023 protocol no. D361BC00001. Capivasertib is an ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here